DK1320522T3 - Achirale analoger af CC-1065 og af duocarmyciner samt præparater og metoder til anvendelse deraf - Google Patents

Achirale analoger af CC-1065 og af duocarmyciner samt præparater og metoder til anvendelse deraf

Info

Publication number: DK1320522T3
Authority: DK; Denmark
Prior art keywords: duocarmycins; achiral; preparations; methods; well
Prior art date: 2000-09-19

Application number

DK01973146T

Other languages

English (en)

Inventor

Moses Lee

Original Assignee

Moses Lee

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-19

Filing date

2001-09-19

Publication date

2006-04-03

2001-09-19 Application filed by Moses Lee filed Critical Moses Lee

2006-04-03 Application granted granted Critical

2006-04-03 Publication of DK1320522T3 publication Critical patent/DK1320522T3/da

Links

229960005501 duocarmycin Drugs 0.000 title abstract 2
229930184221 duocarmycin Natural products 0.000 title abstract 2
238000000034 method Methods 0.000 title 1
238000002360 preparation method Methods 0.000 title 1
CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 abstract 2
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 2
XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 abstract 2
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 abstract 1
AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 abstract 1
LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 abstract 1
125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
229940100198 alkylating agent Drugs 0.000 abstract 1
239000002168 alkylating agent Substances 0.000 abstract 1
239000011230 binding agent Substances 0.000 abstract 1
230000003993 interaction Effects 0.000 abstract 1
VQAFBYLFRCCWNB-GOSISDBHSA-N n-[2-[(1s)-1-(chloromethyl)-5-hydroxy-9-methyl-1,2-dihydrobenzo[e]indole-3-carbonyl]imidazo[1,2-a]pyridin-6-yl]-4-hydroxybenzamide Chemical compound C1([C@H](CCl)C2)=C3C(C)=CC=CC3=C(O)C=C1N2C(=O)C(N=C1C=C2)=CN1C=C2NC(=O)C1=CC=C(O)C=C1 VQAFBYLFRCCWNB-GOSISDBHSA-N 0.000 abstract 1
125000001453 quaternary ammonium group Chemical group 0.000 abstract 1
JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/416—2,5-Pyrrolidine-diones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/74—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C215/76—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton of the same non-condensed six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/38—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
- C07C271/28—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a non-condensed six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/26—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring
- C07C271/30—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a six-membered aromatic ring to a carbon atom of a six-membered aromatic ring being part of a condensed ring system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyrrole Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

DK01973146T 2000-09-19 2001-09-19 Achirale analoger af CC-1065 og af duocarmyciner samt præparater og metoder til anvendelse deraf DK1320522T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US66616000A	2000-09-19	2000-09-19

Publications (1)

Publication Number	Publication Date
DK1320522T3 true DK1320522T3 (da)	2006-04-03

Family

ID=24673061

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01973146T DK1320522T3 (da)	2000-09-19	2001-09-19	Achirale analoger af CC-1065 og af duocarmyciner samt præparater og metoder til anvendelse deraf

Country Status (9)

Country	Link
US (1)	US6660742B2 (da)
EP (1)	EP1320522B8 (da)
JP (1)	JP5010089B2 (da)
CN (1)	CN1315805C (da)
AT (1)	ATE310724T1 (da)
DE (1)	DE60115265T2 (da)
DK (1)	DK1320522T3 (da)
ES (1)	ES2254492T3 (da)
WO (1)	WO2002030894A2 (da)

Families Citing this family (105)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY125533A (en) *	1999-12-06	2006-08-30	Bristol Myers Squibb Co	Heterocyclic dihydropyrimidine compounds
PT1392359E (pt)	2001-05-11	2010-01-27	Ludwig Inst For Cancer Res Ltd	Proteínas de ligação específica e suas utilizações
US20100056762A1 (en)	2001-05-11	2010-03-04	Old Lloyd J	Specific binding proteins and uses thereof
TW200307539A (en) *	2002-02-01	2003-12-16	Bristol Myers Squibb Co	Cycloalkyl inhibitors of potassium channel function
GB0205176D0 (en) *	2002-03-06	2002-04-17	Astrazeneca Ab	Chemical compounds
TW200403058A (en) *	2002-04-19	2004-03-01	Bristol Myers Squibb Co	Heterocyclo inhibitors of potassium channel function
JP2006505571A (ja) *	2002-10-15	2006-02-16	リゲルファーマシューテイカルズ、インコーポレイテッド	置換されたインドール及びｈｃｖ阻害剤としてのその使用
US7208491B2 (en) *	2003-02-07	2007-04-24	Hoffmann-La Roche Inc.	N-monoacylated o-phenylenediamines
US7078419B2 (en)	2003-03-10	2006-07-18	Boehringer Ingelheim Pharmaceuticals, Inc.	Cytokine inhibitors
WO2005032594A2 (en) *	2003-10-03	2005-04-14	The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Alkylators linked to polyamides as dna binding agents
EA200901236A1 (ru) *	2004-03-16	2009-12-30	Темпл Юниверсити - Оф Дзе Коммонвелт Систем Оф Хайер Эдьюкейшн	Замещённые фенокси- и фенилтиопроизводные для лечения пролиферативных нарушений
WO2006053274A2 (en) *	2004-11-15	2006-05-18	Bristol-Myers Squibb Company	2-amino-1-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
WO2006055462A1 (en)	2004-11-15	2006-05-26	Bristol-Myers Squibb Company	2-amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
US7365061B2 (en) *	2004-11-15	2008-04-29	Bristol-Myers Squibb Company	2-Amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
WO2006055435A1 (en) *	2004-11-15	2006-05-26	Bristol-Myers Squibb Company	2-aminonaphthalene derivatives and related glycogen phosphorylase inhibitors
US8782706B2 (en)	2005-12-29	2014-07-15	United Video Properties	Systems and methods for providing channel groups in an interactive media guidance application
SI2035369T1 (sl)	2006-07-05	2014-11-28	Fibrotech Therapeutics Pty Ltd	Terapevtske spojine
GB0619325D0 (en) *	2006-09-30	2006-11-08	Univ Strathclyde	New compounds
AR063311A1 (es) *	2006-10-18	2009-01-21	Novartis Ag	Compuestos organicos
WO2008050140A2 (en) *	2006-10-27	2008-05-02	Spirogen Limited	Compounds for treatment of parasitic infection
CN101711284A (zh)	2007-01-25	2010-05-19	达娜-法勃肿瘤研究所	抗egfr抗体在治疗egfr突变体介导的疾病中的用途
JP5618549B2 (ja)	2007-03-15	2014-11-05	ルードヴィッヒインスティテュートフォーキャンサーリサーチリミテッド	Ｅｇｆｒ抗体及びｓｒｃ阻害剤を用いる治療方法及び関連製剤
US9901567B2 (en)	2007-08-01	2018-02-27	Syntarga B.V.	Substituted CC-1065 analogs and their conjugates
EP2188311B1 (en)	2007-08-14	2016-10-05	Ludwig Institute for Cancer Research Ltd.	Monoclonal antibody 175 targeting the egf receptor and derivatives and uses thereof
GB0819095D0 (en)	2008-10-17	2008-11-26	Spirogen Ltd	Pyrrolobenzodiazepines
JP5677970B2 (ja)	2008-11-03	2015-02-25	シンタルガ・ビーブイ	新規ｃｃ−１０６５類似体およびその複合体
US20110076232A1 (en) *	2009-09-29	2011-03-31	Ludwig Institute For Cancer Research	Specific binding proteins and uses thereof
EP2947073B1 (en) *	2009-10-22	2019-04-03	Fibrotech Therapeutics Pty Ltd	Fused ring analogues of anti-fibrotic agents
US8697688B2 (en)	2010-04-15	2014-04-15	Seattle Genetics Inc.	Pyrrolobenzodiazepines used to treat proliferative diseases
MX2012011900A (es)	2010-04-15	2013-03-21	Seattle Genetics Inc	Conjugados de pirrolobenzodiazepina diana.
NO3056203T3 (da)	2010-04-21	2018-05-12
BR112013031819B1 (pt)	2011-06-10	2022-05-03	Mersana Therapeutics, Inc	Suporte polimérico, composição farmacêutica, composto, e, uso do suporte
EP2751120B1 (en)	2011-09-20	2018-08-22	MedImmune Limited	Pyrrolobenzodiazepines as unsymmetrical dimeric pbd compounds for inclusion in targeted conjugates
US9387259B2 (en)	2011-10-14	2016-07-12	Seattle Genetics, Inc.	Pyrrolobenzodiazepines and targeted conjugates
CA2850373C (en)	2011-10-14	2019-07-16	Seattle Genetics, Inc.	Pyrrolobenzodiazepines and targeted conjugates
CN103998450B (zh)	2011-10-14	2017-03-08	麦迪穆有限责任公司	吡咯并苯并二氮杂卓
CN110183470A (zh)	2011-10-14	2019-08-30	麦迪穆有限责任公司	吡咯并苯并二氮杂卓
CN102827061A (zh) *	2012-09-19	2012-12-19	兰州大学	5,6,7-三甲氧基吲哚类衍生物、制备方法及用途
WO2014057120A1 (en)	2012-10-12	2014-04-17	Adc Therapeutics Sàrl	Pyrrolobenzodiazepine-antibody conjugates
ES2680153T3 (es)	2012-10-12	2018-09-04	Adc Therapeutics Sa	Conjugados de anticuerpos anti-PSMA-pirrolobenzodiazepinas
EP2906249B1 (en)	2012-10-12	2018-06-27	MedImmune Limited	Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation
PL2906251T3 (pl)	2012-10-12	2018-02-28	Adc Therapeutics Sa	Koniugaty pirolobenzodiazepina-przeciwciało anty-CD22
DK2906253T3 (da)	2012-10-12	2018-10-22	Adc Therapeutics Sa	Pyrrolobenzodiazepin-anti-psma-antistofkonjugater
DK2839860T3 (da)	2012-10-12	2019-06-17	Medimmune Ltd	Pyrrolobenzodiazepiner og konjugater deraf
CN110256469B (zh)	2012-10-12	2022-05-17	麦迪穆有限责任公司	吡咯并苯并二氮杂卓及其结合物
MX364329B (es)	2012-10-12	2019-04-23	Medimmune Ltd	Conjugados del anticuerpo pirrolobenzodiazepina.
WO2014057119A1 (en)	2012-10-12	2014-04-17	Adc Therapeutics Sàrl	Pyrrolobenzodiazepine-antibody conjugates
JP6334553B2 (ja)	2012-12-10	2018-05-30	メルサナセラピューティクス，インコーポレイティド	タンパク質−高分子−薬剤コンジュゲート
US9872918B2 (en)	2012-12-12	2018-01-23	Mersana Therapeutics, Inc.	Hydroxyl-polymer-drug-protein conjugates
EA031585B1 (ru)	2012-12-21	2019-01-31	Медимьюн Лимитед	Пирролобензодиазепины и их конъюгаты
CN105246894A (zh)	2012-12-21	2016-01-13	斯皮罗根有限公司	用于治疗增殖性和自身免疫疾病的非对称吡咯并苯并二氮杂卓二聚物
CN105142674B (zh)	2013-03-13	2018-11-13	麦迪穆有限责任公司	吡咯并苯并二氮杂卓和其结合物
NZ710745A (en)	2013-03-13	2019-03-29	Genentech Inc	Pyrrolobenzodiazepines and conjugates thereof
KR102087850B1 (ko)	2013-10-11	2020-03-12	메르사나 테라퓨틱스, 인코포레이티드	단백질-고분자-약물 접합체
ES2754397T3 (es)	2013-10-11	2020-04-17	Asana Biosciences Llc	Conjugados de proteína-polímero-fármaco
US9956299B2 (en)	2013-10-11	2018-05-01	Medimmune Limited	Pyrrolobenzodiazepine—antibody conjugates
US9950078B2 (en)	2013-10-11	2018-04-24	Medimmune Limited	Pyrrolobenzodiazepine-antibody conjugates
GB201317982D0 (en)	2013-10-11	2013-11-27	Spirogen Sarl	Pyrrolobenzodiazepines and conjugates thereof
GB201317981D0 (en)	2013-10-11	2013-11-27	Spirogen Sarl	Pyrrolobenzodiazepines and conjugates thereof
US10010624B2 (en)	2013-10-11	2018-07-03	Medimmune Limited	Pyrrolobenzodiazepine-antibody conjugates
HUE029672T2 (en)	2014-01-10	2017-03-28	Synthon Biopharmaceuticals Bv	Duokarmicin-ADCs for use in the treatment of endometrial cancer
MX373458B (es)	2014-01-10	2020-05-11	Byondis Bv	Metodo para purificar conjugados de anticuerpo-farmaco enlazados a cisteina.
ES2668984T3 (es)	2014-01-10	2018-05-23	Synthon Biopharmaceuticals B.V.	CAF de duocarmicina para su uso en el tratamiento del cáncer de vejiga
GB201416112D0 (en)	2014-09-12	2014-10-29	Medimmune Ltd	Pyrrolobenzodiazepines and conjugates thereof
CN107148285B (zh)	2014-11-25	2022-01-04	Adc治疗股份有限公司	吡咯并苯并二氮杂䓬-抗体缀合物
GB201506402D0 (en)	2015-04-15	2015-05-27	Berkel Patricius H C Van And Howard Philip W	Site-specific antibody-drug conjugates
GB201506411D0 (en)	2015-04-15	2015-05-27	Bergenbio As	Humanized anti-axl antibodies
DE102016105449A1 (de) *	2015-10-29	2017-05-04	Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts	Bifunktionale Prodrugs
GB201601431D0 (en)	2016-01-26	2016-03-09	Medimmune Ltd	Pyrrolobenzodiazepines
GB201602359D0 (en)	2016-02-10	2016-03-23	Medimmune Ltd	Pyrrolobenzodiazepine Conjugates
GB201602356D0 (en)	2016-02-10	2016-03-23	Medimmune Ltd	Pyrrolobenzodiazepine Conjugates
GB201607478D0 (en)	2016-04-29	2016-06-15	Medimmune Ltd	Pyrrolobenzodiazepine Conjugates
EP3474901B1 (en)	2016-06-27	2025-08-06	Tagworks Pharmaceuticals B.V.	Cleavable tetrazine used in bio-orthogonal drug activation
GB201617466D0 (en)	2016-10-14	2016-11-30	Medimmune Ltd	Pyrrolobenzodiazepine conjugates
US11135307B2 (en)	2016-11-23	2021-10-05	Mersana Therapeutics, Inc.	Peptide-containing linkers for antibody-drug conjugates
AU2018215089C1 (en)	2017-02-03	2022-09-22	Certa Therapeutics Pty. Ltd.	Anti-fibrotic compounds
GB201702031D0 (en)	2017-02-08	2017-03-22	Medlmmune Ltd	Pyrrolobenzodiazepine-antibody conjugates
BR112019016373B1 (pt)	2017-02-08	2022-01-25	Medimmune Limited	Conjugado anticorpo-fármaco que se liga ao axl, composição e composição farmacêutica que compreende o mesmo e uso terapêutico do dito conjugado
ES2926144T3 (es)	2017-04-18	2022-10-24	Medimmune Ltd	Conjugados de pirrolobenzodiazepina
JP7408396B2 (ja)	2017-04-20	2024-01-05	アーデーセーセラピューティクスソシエテアノニム	併用療法
PL3638373T3 (pl)	2017-06-14	2025-04-14	Adc Therapeutics Sa	Schematy dawkowania dla podawania ADC anty-CD19
TW201905037A (zh)	2017-06-22	2019-02-01	美商梅爾莎納醫療公司	藥物攜帶聚合物支架及蛋白質聚合物藥物共軛物之製造方法
EP3668874B1 (en)	2017-08-18	2021-12-22	Medimmune Limited	Pyrrolobenzodiazepine conjugates
GB201803342D0 (en)	2018-03-01	2018-04-18	Medimmune Ltd	Methods
GB201806022D0 (en)	2018-04-12	2018-05-30	Medimmune Ltd	Pyrrolobenzodiazepines and conjugates thereof
ES2975330T3 (es)	2018-05-04	2024-07-04	Tagworks Pharmaceuticals B V	Compuestos que comprenden un enlazador para aumentar la estabilidad del trans-cicloocteno
WO2019212356A1 (en)	2018-05-04	2019-11-07	Tagworks Pharmaceuticals B .V.	Tetrazines for high click conjugation yield in vivo and high click release yield
EP3873534A1 (en)	2018-10-29	2021-09-08	Mersana Therapeutics, Inc.	Cysteine engineered antibody-drug conjugates with peptide-containing linkers
MX2021010477A (es)	2019-03-15	2021-10-01	Medimmune Ltd	Dimeros de azetidobenzodiazepina y conjugados que los comprenden para uso en el tratamiento de cancer.
IL289094A (en)	2019-06-17	2022-02-01	Tagworks Pharmaceuticals B V	Tetrazines for increasing the speed and yield of the "click release" reaction
WO2020256546A1 (en)	2019-06-17	2020-12-24	Tagworks Pharmaceuticals B.V.	Compounds for fast and efficient click release
WO2021040393A1 (ko) *	2019-08-26	2021-03-04	국제약품 주식회사	인돌 카복사미드 유도체 및 그를 포함하는 약제학적 조성물
EP4399283A2 (en)	2021-09-06	2024-07-17	Veraxa Biotech GmbH	Novel aminoacyl-trna synthetase variants for genetic code expansion in eukaryotes
EP4186529B1 (en)	2021-11-25	2025-07-09	Veraxa Biotech GmbH	Improved antibody-payload conjugates (apcs) prepared by site-specific conjugation utilizing genetic code expansion
JP2024543916A (ja)	2021-11-25	2024-11-26	ヴェラクサバイオテックゲーエムベーハー	遺伝暗号拡張を利用した部位特異的結合によって調製された改良された抗体ペイロード複合体（ａｐｃ）
CN118574641A (zh)	2021-12-08	2024-08-30	欧洲分子生物学实验室	用于制备靶向偶联物的亲水性四嗪官能化的负载物
US20250114489A1 (en)	2022-02-15	2025-04-10	Tagworks Pharmaceuticals B.V.	Masked il12 protein
CA3261603A1 (en)	2022-07-15	2024-01-18	Pheon Therapeutics Ltd	ANTIBODY-DRUG CONJUGATES
AU2023358214A1 (en)	2022-10-12	2025-05-08	Tagworks Pharmaceuticals B.V.	Strained bicyclononenes
WO2024153789A1 (en)	2023-01-20	2024-07-25	Basf Se	Stabilized biopolymer composition, their manufacture and use
CN121100004A (zh)	2023-03-10	2025-12-09	泰克沃尔科斯制药有限公司	具有改进的t-连接子的反式-环辛烯
WO2025021929A1 (en)	2023-07-27	2025-01-30	Veraxa Biotech Gmbh	Hydrophilic trans-cyclooctene (hytco) compounds, constructs and conjugates containing the same
WO2025056807A1 (en)	2023-09-15	2025-03-20	Basf Se	Stabilized biopolymer composition, their manufacture and use
WO2025149667A1 (en)	2024-01-12	2025-07-17	Pheon Therapeutics Ltd	Antibody drug conjugates and uses thereof
WO2025174248A1 (en)	2024-02-16	2025-08-21	Tagworks Pharmaceuticals B.V.	Trans-cyclooctenes with "or gate" release

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69733942T2 (de) *	1996-03-08	2006-06-08	The Scripps Research Institute, La Jolla	Mcbi analoge von cc-1065 und die duocarmycine
US5843937A (en) *	1996-05-23	1998-12-01	Panorama Research, Inc.	DNA-binding indole derivatives, their prodrugs and immunoconjugates as anticancer agents
EP0934269A4 (en) *	1996-05-31	2000-01-12	Scripps Research Inst	ANALOGS OF CC-1065 AND DUOCARMYCINE
IL135616A0 (en) *	1997-10-14	2001-05-20	Scripps Research Inst	Iso-cbi and iso-ci analogs of cc-1065 and the duocarmycins
JP3045706B1 (ja) *	1998-09-14	2000-05-29	科学技術振興事業団	Ｄｎａの特定塩基配列をアルキル化する化合物及びその合成法

2001
- 2001-09-19 AT AT01973146T patent/ATE310724T1/de not_active IP Right Cessation
- 2001-09-19 WO PCT/US2001/029160 patent/WO2002030894A2/en not_active Ceased
- 2001-09-19 JP JP2002534280A patent/JP5010089B2/ja not_active Expired - Fee Related
- 2001-09-19 DK DK01973146T patent/DK1320522T3/da active
- 2001-09-19 DE DE60115265T patent/DE60115265T2/de not_active Expired - Lifetime
- 2001-09-19 EP EP01973146A patent/EP1320522B8/en not_active Expired - Lifetime
- 2001-09-19 US US09/955,062 patent/US6660742B2/en not_active Expired - Lifetime
- 2001-09-19 CN CNB018159346A patent/CN1315805C/zh not_active Expired - Fee Related
- 2001-09-19 ES ES01973146T patent/ES2254492T3/es not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CN1315805C (zh)	2007-05-16
WO2002030894A3 (en)	2002-06-20
ATE310724T1 (de)	2005-12-15
US6660742B2 (en)	2003-12-09
DE60115265D1 (de)	2005-12-29
JP5010089B2 (ja)	2012-08-29
DE60115265T2 (de)	2006-08-10
WO2002030894A2 (en)	2002-04-18
JP2004511466A (ja)	2004-04-15
CN1461298A (zh)	2003-12-10
EP1320522B8 (en)	2006-02-01
EP1320522B1 (en)	2005-11-23
US20030073731A1 (en)	2003-04-17
EP1320522A2 (en)	2003-06-25
ES2254492T3 (es)	2006-06-16

Publication	Publication Date	Title
DK1320522T3 (da)	2006-04-03	Achirale analoger af CC-1065 og af duocarmyciner samt præparater og metoder til anvendelse deraf
CY1111278T1 (el)	2015-08-05	Συστημα ασφαλειας
NO308601B1 (no)	2000-10-02	Tricykliske benzazepiner og farmasøytisk preparat inneholdende disse
DE69534300D1 (de)	2005-08-11	Neues multimerisierendes reagenz
BR0113931A (pt)	2004-01-13	Compostos heterocìclicos ligantes receptores de quimiocinas
DK0911333T3 (da)	2002-07-01	Pyrazol [4,3-d]pyrimidinderivater og farmaceutiske præparater, der indeholder disse
TNSN06186A1 (fr)	2007-11-15	Pyrido [2,3-d] pyrimidine -2, 4-diamines servant d'inhibiteurs de pde 2
ATE274348T1 (de)	2004-09-15	Überbrückte indenopyrrolocarbazole
EA200500899A1 (ru)	2006-02-24	Антагонисты аденозиндифосфатного рецептора тромбоцитов
ATE438398T1 (de)	2009-08-15	Pyrrolo-dihydroisochinolin-derivate als pde10- inhibitoren
DE69828080D1 (de)	2005-01-13	Pyrimidinderivate als markierte bindungspartner
DE69524103D1 (de)	2002-01-03	Fluorinierte 2-nitroimidazole analoge zur detektion von hypoxischen tumorzellen
BR0115121A (pt)	2003-09-30	Compostos n-((1,2,4)triazoloazinil)tiofenossulfonamida como herbicidas
ES2166128T3 (es)	2002-04-01	Mezcla fungicida.
ATE496056T1 (de)	2011-02-15	Pyrimidinverbindungen mit phosphonatgruppen als antivirale nucleotidanaloga
GR1000495B (el)	1992-07-30	Υγρα υδατικη θιξοτροπικη απορρυπαντικη συνθεση δι αυτοματα πλυντηρια πιατων.
IL136911A0 (en)	2001-06-14	Heterocyclic topoisomerase poisons
MA27501A1 (fr)	2005-08-01	Derives d'imidazoquinoline en tant que ligands recepteurs de l'adenosine a3
ATE501270T1 (de)	2011-03-15	Nukleinsäure-extraktion-lösung und gebrauch davon
EP1314730A4 (en)	2004-07-14	REAGENT FOR DETERMINING SINGLET OXYGEN
BR0115996A (pt)	2004-01-06	Sulfamidotienopirimidinas
DK1325923T3 (da)	2007-04-02	Cephem-forbindelser og ESBL-detekterende reagenser indeholdende disse
DK0871612T3 (da)	2003-07-14	Kondenserede isoindoloner som proteinkinase C-inhibitorer
ATE441642T1 (de)	2009-09-15	Hydantoin derivate mit affinität für somatostatin rezeptoren
BR9913282A (pt)	2001-05-15	3-aril-pirazóis substituìdos